Back to Results
First PageMeta Content



October 8, 2015 Regeneron and Sanofi Announce Publication of Positive Phase 2b Dupilumab Data in The Lancet Study Evaluated Adult Patients with Moderate-to-Severe Atopic Dermatitis who were Inadequately Controlled by To
Add to Reading List

Open Document

File Size: 17,54 KB

Share Result on Facebook
UPDATE